Table 2.
Model 1, β (95% CI, P) | Model 2, β (95% CI, P) | Model 3, β (95% CI, P) | |
---|---|---|---|
Non-arthritis | Reference | Reference | Reference |
Arthritis | 0.007 (− 0.001, 0.015) 0.0861 | 0.017 (0.008, 0.025) 0.0001 | 0.018 (0.010, 0.027) < 0.0001 |
Non-arthritis | Reference | Reference | Reference |
Osteoarthritis or degenerative arthritis | 0.013 (0.001, 0.025) 0.0293 | 0.023 (0.012, 0.035) 0.0001 | 0.023 (0.011, 0.035) 0.0001 |
Rheumatoid arthritis | 0.000 (− 0.017, 0.018) 0.9733 | 0.010 (− 0.007, 0.027) 0.2599 | 0.014 (− 0.003, 0.031) 0.1074 |
Psoriatic arthritis | 0.005 (− 0.039, 0.049) 0.8177 | 0.020 (0.000, 0.039) 0.0445 | 0.024 (0.005, 0.043) 0.0133 |
Do not know or refused | 0.000 (− 0.015, 0.015) 0.9712 | 0.008 (− 0.006, 0.023) 0.2665 | 0.011 (− 0.004, 0.026) 0.1350 |
Model 1 no covariates were adjusted; Model 2 age, gender, and race were adjusted; Model 3 age, gender, race, educational level, body mass index, ratio of family income to poverty, vigorous recreational activities, smoked at least 100 cigarettes in life, blood urea nitrogen, total protein, total cholesterol, alkaline phosphatase, serum uric acid, serum sodium, serum potassium, serum phosphorus, and serum calcium were adjusted